Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    MagForce

    MCap

    —

    Last close

    -0.02

    ▲ 0.01 (100.00%)

    DFR Gold

    MCap

    CAD16m

    Last close

    CAD0.10

    ▲ 0.03 (42.86%)

    Context Therapeutics

    MCap

    USD17m

    Last close

    USD1.06

    ▲ 0.19 (21.84%)

  • Sectors

    Sectors

  • Investment Strategy

    Investment Strategy

    View All

    Latest

  • Thematics

    Thematics

    View All Thematics

    Latest

Cantargia – Edison Open House interview

Cantargia – Edison Open House interview

Associated equity: Cantargia

Cantargia is a clinical-stage biotechnology company based in Sweden. It is developing two assets against IL1RAP, CAN04 and CAN10. CAN04 is being studied in several solid tumours with a main focus on non-small cell lung cancer (NSCLC) and pancreatic cancer. The most advanced trial is in Phase II.

View this company

Cantargia — 8 videos in collection

< Previous
Next >

You may also be interested in these:

Healthcare

Cantargia - executive interview

Healthcare

Cantargia – executive interview

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free